IMRN logo

Immuron Limited (IMRN)

Profile

Full Name

Immuron Limited

Ticker Symbol

IMRN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

June 9, 2017

Indexes

Not included

Website

http://www.immuron.com.au

Employees

7

Key Details

Price

$1.73(-5.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.21M(+164.72% YoY)

Annual EPS

-$0.80(-78.46% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.73
IMRN price is $1.73

30-Day Relative Volume

4.23
IMRN 30-day relative volume is 4.23

Price Performance

Price Most recent change

-5%
IMRN price was down -5% on Apr 15, 2025

Price YTD change

+1.76%
IMRN price is up +1.76% since January 1st

Price 1-year change

-33.2%
IMRN price is down -33.2% year-on-year

Price 3-year change

-41.55%
IMRN price is down -41.55% over the past 3 years

Price Range

Price All-time high

$28.99
IMRN price is currently -94.03% below its historical high of $28.99

Price 3-year low

$1.39
IMRN price is currently +24.46% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.91M
IMRN market capitalization is $9.91 million

Market cap 3-year change

-41.21%
IMRN market capitalization is down -41.21% over the past 3 years

Market cap All-time high

$88.61M
IMRN market capitalization is currently -88.82% below its historical high of $88.61 million

Market cap sector rank

19.49%
IMRN market capitalization is higher than 19.49% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.59%
IMRN shares outstanding is up +0.59% year-on-year

Shares Outstanding 3-Year Change

+0.59%
IMRN shares outstanding is up +0.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.57
IMRN beta is 0.57

200-day SMA

$2.15
IMRN price is currently -19.41% below its 200-day simple moving average

50-day SMA

$1.85
IMRN price is currently -6.51% below its 50-day simple moving average

RSI

45.39
IMRN 14-day relative strength index is 45.39

Volume

4.23
IMRN 30-day relative volume is 4.23

ATR

$0.19
IMRN average true range is $0.19

10-day Historical Volatility

56.12%
IMRN 10-day historical volatility is 56.12%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.21M
IMRN annual revenue is $3.21 million

Revenue Analysts estimate

$5.50M
IMRN annual revenue is currently -41.56% lower than the consensus analysts' forecast

Revenue 1-year change

+164.72%
IMRN annual revenue is up +164.72% year-on-year

Revenue Sector rank

18.7%
IMRN annual revenue is higher than 18.7% of companies in Healthcare sector

EPS

EPS

-$0.80
IMRN annual earnings per share is -$0.80

EPS Analysts estimate

-
IMRN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-78.46%
IMRN annual earnings per share is down -78.46% year-on-year

EPS Sector rank

61.04%
IMRN annual earnings per share is higher than 61.04% of companies in Healthcare sector

Profit

Gross profit

$2.19M
IMRN annual gross profit is $2.19 million

Gross margin

68.06%
IMRN annual gross profit margin is 68.06%

Operating profit

-$3.42M
IMRN annual operating income is -$3.42 million

Operating margin

-106.38%
IMRN annual operating profit margin is -106.38%

Net income

-$4.55M
IMRN annual net profit is -$4.55 million

Net margin

-141.49%
IMRN annual net profit margin is -141.49%

Expenses

Total expenses

$6.63M
IMRN annual total expenses is $6.63 million

Operating expenses

$5.61M
IMRN annual total operating expenses is $5.61 million

Cost of goods sold

$1.03M
IMRN annual cost of goods sold is $1.03 million

Selling, general & administrative expenses

$4.29M
IMRN annual SGA is $4.29 million

Depreciation and amortization

-
IMRN annual depreciation & amortization value is unknown

Interest expense

$5000.00
IMRN annual interest expense is $5000.00

Income tax

$0.00
IMRN annual income tax is $0.00

EBIT & EBITDA

EBIT

-$4.54M
IMRN annual earnings before interest & taxes is -$4.54 million

EBITDA

-$4.51M
IMRN annual EBITDA is -$4.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$10.39M
IMRN annual total assets is $10.39 million

Non current assets

$550.50K
IMRN annual long term assets is $550.50 thousand

Current assets

$9.84M
IMRN annual total current assets is $9.84 million

Cash and cash equivalents

$7.79M
IMRN annual cash & cash equivalents is $7.79 million

Accounts receivable

$395.20K
IMRN annual accounts receivable is $395.20 thousand

Inventory

$1.06M
IMRN annual inventory is $1.06 million

Liabilities

Total liabilities

$1.90M
IMRN annual total liabilities is $1.90 million

Long term liabilities

$94.60K
IMRN annual total long term liabilities is $94.60 thousand

Current liabilities

$1.80M
IMRN annual total current liabilities is $1.80 million

Accounts payable

$433.70K
IMRN annual accounts payable is $433.70 thousand

Debt

Total debt

$116.00K
IMRN annual total debt is $116.00 thousand

Total debt 1-year change

-7.35%
IMRN annual total debt is down -7.35% year-on-year

Long term debt

$88.90K
IMRN annual long term debt is $88.90 thousand

Short term debt

$27.10K
IMRN annual short term debt is $27.10 thousand

Equity & Capital

Shareholders equity

$8.49M
IMRN annual stockholders equity is $8.49 million

Book value

$8.49M
IMRN annual book value is $8.49 million

Retained earnings

-$52.78M
IMRN annual retained earnings is -$52.78 million

Working capital

$8.04M
IMRN annual working capital is $8.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
IMRN annual cash flow from operations value is unknown

Cash from operations 1-year change

-
IMRN annual cash flow from operations 1-year change is unknown

Cash from investing

$214.70K
IMRN annual cash flow from investing activities is $214.70 thousand

Cash from investing 1-year change

+112.17%
IMRN annual cash flow from investing activities is up +112.17% year-on-year

Cash from financing

$500.00
IMRN annual cash flow from financing activities is $500.00

Cash from financing 1-year change

+101.66%
IMRN annual cash flow from financing activities is up +101.66% year-on-year

CAPEX

CAPEX

$100.00
IMRN annual capital expenditures is $100.00

CAPEX 1-year change

-98.08%
IMRN annual capital expenditures is down -98.08% year-on-year

Free Cash Flow

Free cash flow

-
IMRN annual free cash flow value is unknown

Free cash flow 1-year change

-
IMRN annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

68.06%
IMRN annual gross profit margin is 68.06%

Operating margin

-106.38%
IMRN annual operating profit margin is -106.38%

Net margin

-141.49%
IMRN annual net profit margin is -141.49%

ROA & ROE

ROA

-36.46%
IMRN annual return on assets is -36.46%

ROE

-42.34%
IMRN annual return on equity is -42.34%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IMRN price to earnings ratio value is unknown

PE ratio Sector rank

-
IMRN price to earnings ratio is unknown

PB Ratio

PB ratio

1.54
IMRN price to book ratio is 1.54

PB ratio Sector rank

56.38%
IMRN price to book ratio is higher than 56.38% of companies in Healthcare sector

PS Ratio

PS ratio

-
IMRN price to sales ratio value is unknown

PS ratio Sector rank

-
IMRN price to sales ratio is unknown

Enterprise value

Enterprise value

$5.10M
IMRN enterprise value is $5.10 million

Enterprise value Sector rank

19.67%
IMRN enterprise value is higher than 19.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
IMRN EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
IMRN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.46
IMRN annual current ratio is 5.46

Quick ratio

4.87
IMRN annual quick ratio is 4.87

Leverage

Debt to equity

0.00
IMRN annual debt to equity ratio is 0.00

Interest coverage ratio

-908.54
IMRN annual interest coverage ratio is -908.54

Risk & Stability

Piotroski F-Score

-
IMRN piotroski f-score value is unknown

Altman Z-Score

-4.18
IMRN altman z-score is -4.18

Analyst ratings

Recent major analysts updates

Sep 26, 24 Litchfield Hills
Buy
Oct 18, 17 HC Wainwright & Co.
Buy
Oct 18, 17 H.C. Wainwright
Buy

Institutional Ownership

Similar stocks

BTAI logo
BioXcel Therapeutics (BTAI)
EKSO logo
Ekso Bionics Holdings (EKSO)
TLPH logo
Talphera (TLPH)
Kindly MD (KDLY)
BSGM logo
BioSig Technologies (BSGM)
RLMD logo
Relmada Therapeutics (RLMD)
XTLB logo
XTL Biopharmaceuticals (XTLB)
HOOK logo
HOOKIPA Pharma (HOOK)
NERV logo
Minerva Neurosciences (NERV)
  • What is the ticker symbol for Immuron Limited?
  • Does Immuron Limited pay dividends?
  • What sector is Immuron Limited in?
  • What industry is Immuron Limited in?
  • What country is Immuron Limited based in?
  • When did Immuron Limited go public?
  • Is Immuron Limited in the S&P 500?
  • Is Immuron Limited in the NASDAQ 100?
  • Is Immuron Limited in the Dow Jones?
  • When was Immuron Limited's last earnings report?
  • When does Immuron Limited report earnings?

What is the ticker symbol for Immuron Limited?

The ticker symbol for Immuron Limited is NASDAQ:IMRN

Does Immuron Limited pay dividends?

No, Immuron Limited does not pay dividends

What sector is Immuron Limited in?

Immuron Limited is in the Healthcare sector

What industry is Immuron Limited in?

Immuron Limited is in the Biotechnology industry

What country is Immuron Limited based in?

Immuron Limited is headquartered in Australia

When did Immuron Limited go public?

Immuron Limited's initial public offering (IPO) was on June 9, 2017

Is Immuron Limited in the S&P 500?

No, Immuron Limited is not included in the S&P 500 index

Is Immuron Limited in the NASDAQ 100?

No, Immuron Limited is not included in the NASDAQ 100 index

Is Immuron Limited in the Dow Jones?

No, Immuron Limited is not included in the Dow Jones index

When was Immuron Limited's last earnings report?

Immuron Limited's most recent earnings report was on Feb 25, 2021

When does Immuron Limited report earnings?

The date for Immuron Limited's next earnings report has not been announced yet
On this page